The MTA Study tracked ADHD children's growth over time and found that those treated with Ritalin grew significantly shorter than non-medicated peers. Researchers initially thought this gap would close during adolescence, but a 2017 follow-up revealed it extended into adulthood. Moreover, the study also indicated that the benefits of Ritalin on attention may diminish after the first year, as no academic performance improvements were noted, leading to serious discussions on the long-term impacts of ADHD medications.
The researchers in the MTA Study found that children with ADHD on Ritalin showed a significant height gap compared to non-medicated peers, persisting into adulthood.
The MTA study revealed that while Ritalin may help with ADHD symptoms initially, the benefits seem to cease after the first year, raising concerns.
Collection
[
|
...
]